KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $12.20 $17.80 Friday, 26th Apr 2024 ENTA stock ended at $12.37. This is 0.88% less than the trading day before Thursday, 25th Apr 2024. During the day the stock fluctuated 3.66% from a day low at $12.20 to a day high of $12.65.
90 days $11.01 $17.80
52 weeks $8.08 $37.75

Historical Enanta Pharmaceuticals prices

Date Open High Low Close Volume
Apr 26, 2024 $12.48 $12.65 $12.20 $12.37 65 645
Apr 25, 2024 $12.62 $12.74 $12.40 $12.48 74 721
Apr 24, 2024 $13.02 $13.21 $12.63 $12.92 90 291
Apr 23, 2024 $13.37 $13.71 $13.04 $13.15 108 198
Apr 22, 2024 $13.46 $13.83 $13.16 $13.44 64 920
Apr 19, 2024 $13.10 $13.44 $12.77 $13.32 136 813
Apr 18, 2024 $13.87 $13.94 $13.22 $13.23 150 456
Apr 17, 2024 $15.33 $15.40 $13.97 $14.00 189 471
Apr 16, 2024 $16.03 $16.13 $15.33 $15.36 209 856
Apr 15, 2024 $16.46 $16.60 $16.05 $16.15 160 047
Apr 12, 2024 $16.72 $16.75 $16.25 $16.45 148 998
Apr 11, 2024 $16.75 $17.03 $16.53 $16.75 131 528
Apr 10, 2024 $16.53 $16.72 $16.08 $16.54 189 864
Apr 09, 2024 $16.34 $16.96 $16.34 $16.82 122 758
Apr 08, 2024 $16.55 $16.62 $16.32 $16.36 161 269
Apr 05, 2024 $16.10 $16.97 $15.75 $16.51 236 011
Apr 04, 2024 $16.92 $17.60 $16.09 $16.18 275 870
Apr 03, 2024 $16.32 $16.86 $16.24 $16.71 193 541
Apr 02, 2024 $16.85 $16.87 $16.09 $16.35 173 666
Apr 01, 2024 $17.77 $17.80 $16.92 $17.02 248 728
Mar 28, 2024 $16.71 $17.76 $16.50 $17.46 299 052
Mar 27, 2024 $16.47 $17.01 $16.23 $16.53 404 321
Mar 26, 2024 $14.20 $16.48 $14.20 $15.95 475 200
Mar 25, 2024 $14.47 $14.80 $13.86 $13.94 130 873
Mar 22, 2024 $14.72 $15.25 $14.47 $14.59 164 838
Click to get the best stock tips daily for free!

About Enanta Pharmaceuticals

Enanta Pharmaceuticals Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and license agreement with Abbott Laboratories to identify, develop, and commercialize HCV NS3 and NS3/4A pro... ENTA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT